LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (drug combination treatments). Dataset 1 of 2: Cell count and normalized growth rate inhibition values. - Dataset (ID:20259)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol 1 Concentration | Small Mol 1 Conc Unit | Small Molecule 2 | Small Mol 2 Concentration | Small Mol 2 Conc Unit | Biological Replicate | Technical Replicate | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Selumetinib | 0.1235 | uM | 0 | uM | 2 | 3 | 1843 | 4374 | 5162 | 0.7889 | |
| BT-20 | Lapatinib | 1.9245 | uM | 0 | uM | 3 | 1 | 280 | 751 | 554 | 1.7239 | |
| BT-20 | NVP-TAE684 | 1.1111 | uM | 0 | uM | 1 | 2 | 2751 | 7137 | 4996 | 2.0262 | |
| BT-20 | 0 | uM | 0 | uM | 1 | 2 | 2751 | 5475 | 4996 | 1.2241 | ||
| BT-20 | Alpelisib | 0.1235 | uM | 0 | uM | 2 | 3 | 1843 | 5422 | 5162 | 1.0672 |